The HCHU can generate new revenue streams for pharma while saving fortunes for tax payers in end of life care for intravenous drug addicts. Those most in need get the help they deserve to improve their health, and society as a whole benefits.
We have opened the door to a large, untapped market of candidates for specialty treatments. We act as the gate-keepers to these patients in order to ensure that pharma companies provide for their care.